www.tabsbuy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Lotemax (Loteprednol)
| Package | Price | Per solution | Savings | Order |
|---|---|---|---|---|
| 0.5% 5ml × 1 solution | € 14.72 | € 14.72 | Add to cart | |
| 0.5% 5ml × 2 solution | € 27.47 | € 13.74 | € 1.96 | Add to cart |
| 0.5% 5ml × 3 solution | € 38.26 | € 12.75 | € 5.89 | Add to cart |
| 0.5% 5ml × 4 solution | € 47.09 | € 11.77 | € 11.77 | Add to cart |
| 0.5% 5ml × 5 solution | € 49.81 | € 9.96 | € 23.77 | Add to cart |
| 0.5% 5ml × 6 solution | € 54.34 | € 9.06 | € 33.96 | Add to cart |
Most popular quantity.
Products from the same category
Country, language and currency
- Testimonials
- Read more »
- Articles
-
- Experts weigh in on the latest ocular surface disease diagnoses and treatments - OSN SuperSite
- OSN SuperSiteExperts weigh in on the latest ocular surface disease diagnoses and treatmentsOSN SuperSiteLotemax (loteprednol etabonate, Bausch + Lomb) would be ideal, and it is also very moisturizing
- Do you change your intraoperative and postoperative management if you lose ... - OSN SuperSite
- OSN SuperSiteDo you change your intraoperative and postoperative management if you lose
- Premier Surgeon: Managing the ocular surface - OSN SuperSite
- OSN SuperSitePremier Surgeon: Managing the ocular surfaceOSN SuperSiteManagement options include concomitant care administered by an internist, rheumatologist or endocrinologist; Restasis (cyclosporine ophthalmic emulsion 0
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
